🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-521647-20-00
Completed Phase I

A research study looking into blood levels of the medicine NNC0487 0111 in the body and how well it is tolerated in people with reduced liver function and normal liver function

2025-521647-20-00 · tracked via the Priya Life Science EU tracker
Sponsor
Novo Nordisk A/S
Sponsor type
Pharmaceutical company
Therapeutic area
Not possible to specify
Decision date
27/04/2026
Enrollment target
35
Sites
Slovakia

Condition studied

hepatic impairment

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-521647-20-00 on CTIS ↗ ← All trials in the EU